109 related articles for article (PubMed ID: 16647238)
21. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
[TBL] [Abstract][Full Text] [Related]
23. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
[TBL] [Abstract][Full Text] [Related]
24. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
26. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
[TBL] [Abstract][Full Text] [Related]
27. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients.
Yang FL; Lee RP; Wang CH; Fang TC; Hsu BG
Ren Fail; 2007; 29(8):997-1001. PubMed ID: 18067047
[TBL] [Abstract][Full Text] [Related]
28. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
[TBL] [Abstract][Full Text] [Related]
30. Factors involved in baseline hyperhomocysteinemia in renal transplantation.
Díaz JM; Sainz Z; Gich I; Guirado LL; Puig T; Oliver A; Montañés R; Chuy E; Solà R
Transplant Proc; 2005 Nov; 37(9):3799-801. PubMed ID: 16386543
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Takahashi N; Shimomura T; Imagawa M; Yufu K; Nawata T; Nakagawa M; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2006 May; 55(5):656-61. PubMed ID: 16631443
[TBL] [Abstract][Full Text] [Related]
32. Relationship between serum nickel and homocysteine concentration in hemodialysis patients.
Katko M; Kiss I; Karpati I; Kadar A; Matyus J; Csongradi E; Posta J; Paragh G; Balla J; Kovacs B; Varga Z
Biol Trace Elem Res; 2008 Sep; 124(3):195-205. PubMed ID: 18465090
[TBL] [Abstract][Full Text] [Related]
33. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
35. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
38. Determining factors of the response to hyperhomocysteinemia treatment in renal transplant patients.
Díaz JM; Sainz Z; Gich I; Guirado LL; Puig T; Oliver A; Montañés R; Facundo C; Chuy E; Solà R
Transplant Proc; 2005 Nov; 37(9):3785-7. PubMed ID: 16386538
[TBL] [Abstract][Full Text] [Related]
39. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
Kalita J; Kumar G; Bansal V; Misra UK
Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients.
Chiu YW; Chang JM; Hwang SJ; Tsai JC; Chen HC
Ren Fail; 2009; 31(4):278-83. PubMed ID: 19462276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
